Category Specific RSS

Algorae Pharmaceuticals

Algorae Pharmaceuticals collaborates with UNSW for AI biopharmaceutical prediction platform for dementia and heart diseases

As of 2023, over 400,000 Australians live with dementia, with over a million people assigned to their care. It is…

2 years ago

Algorae debuts new name with AI modelling partnership with the UNSW

In a promising new chapter, Algorae Pharmaceuticals (ASX: 1AI), formerly known as Living Cell Technologies (ASX: LCT), has debuted its…

2 years ago